Safirstein Metcalf LLP 1-800-221-0015
  • Home
  • Attorneys
  • Cases & Investigations
  • Practice Areas
  • Contact Us 
  • Report Fraud / Join a Case
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Email
Category

Class Action Lawsuit

LendingClub Corporation Shareholder/Investor Class Action Lawsuit

By jamesClass Action Lawsuit, LendingClub Corporation
Safirstein Metcalf LLP Announces that a Class Action has been Filed Against LendingClub Corporation – LC Safirstein Metcalf LLP, announces that a class action lawsuit has been filed on behalf of purchasers of the securities of LendingClub Corporation (NYSE:LC) between February...
Read More
May 25, 2018
Love0

PPG Industries, Inc. Shareholder/Investor Class Action Lawsuit

By jamesClass Action Lawsuit, PPG Industries
Safirstein Metcalf LLP Announces that a Class Action has been Filed Against PPG Industries, Inc. – PPG Safirstein Metcalf LLP announces that a class action lawsuit has been filed against PPG Industries, Inc. (NYSE:PPG) and certain of its officers, on...
Read More
May 25, 2018
Love0

Synergy Pharmaceuticals, Inc Shareholder/Investor Class Action Lawsuit

By jamesClass Action Lawsuit, Synergy Pharmaceuticals
Safirstein Metcalf LLP Announces that a Class Action has been Filed Against Synergy Pharmaceuticals Inc - SGYP Safirstein Metcalf LLP announces that a class action lawsuit has been filed against Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) and certain of its officers, on...
Read More
March 13, 2018
Love0

MiMedx Group, Inc Shareholder/Investor Class Action Investigation

By jamesClass Action Lawsuit, MiMedx
Safirstein Metcalf LLP Announces That Class Actions Have Been Filed Against MiMedx Group, Inc. – MDXG Safirstein Metcalf LLP announces that class action lawsuits have been filed against MiMedx Group, Inc. (NASDAQ:MDXG). The class actions are on behalf of a...
Read More
March 13, 2018
Love0

Obalon Therapeutics, Inc Shareholder/Investor Class Action Lawsuit

By jamesClass Action Lawsuit, Obalon Therapeutics
Safirstein Metcalf LLP Announces that A Class Action Has Been Filed Against Obalon Therapeutics, Inc. – OBLN Safirstein Metcalf LLP announces that a class action lawsuit has been filed against Obalon Therapeutics, Inc. (NASDAQ:OBLN) and certain of its officers, on...
Read More
March 13, 2018
Love0

Ubiquiti Networks Shareholder/Investor Class Action Lawsuit

By jamesClass Action Lawsuit, Ubiquiti Networks
Safirstein Metcalf LLP Announces The Filing Of A Class Action Lawsuit Against Ubiquiti Networks, Inc. ( NASDAQ: UBNT) A class action lawsuit has been filed against Ubiquiti Networks, Inc. (NASDAQ: UBNT) on behalf of a class consisting of investors who...
Read More
February 15, 2018
Love0

GoPro, Inc. Shareholder / Investor Class Action Lawsuit

By jamesClass Action Lawsuit, GoPro Inc
A Class Action Has Been Filed Against GoPro, Inc. (GPRO) - Announcement from Safirstein Metcalf LLC. Safirstein Metcalf LLP announces that a class action has been has been filed against GoPro, Inc. (NASDAQ: GPRO) and certain of its officers.  The class...
Read More
February 15, 2018
Love0

Valeant Pharmaceuticals Shareholder/Investor Class Action Lawsuit

By jamesClass Action Lawsuit, Valeant Pharmaceuticals
Safirstein Metcalf LLP and HGT Law Commence a Securities Fraud Action Against Valeant Pharmaceuticals (VRX) and its Senior Officers on Behalf of Retail Investors On January 19, 2018, Safirstein Metcalf LLP and HGT Law commenced a shareholder “opt-out” lawsuit  on...
Read More
February 15, 2018
Love0

FREE CASE EVALUATION


    Email us OR fill out the form below for a free case evaluation





    • Home
    • Attorneys
    • Cases & Investigations
    • Practice Areas
    • Contact Us
    • Report Fraud / Join a Case
    • Blog

    ​

    SAFIRSTEIN METCALF LLP - ATTORNEY ADVERTISING.
    ​PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.

    ​1-800-221-0015
    info@safirsteinmetcalf.com
    ​
    ​Terms and Conditions

    © 2021 Safirstein Metcalf LLP 1-800-221-0015. All Rights Reserved.

    • Home
    • Attorneys
    • Cases & Investigations
    • Practice Areas
    • Contact Us 
    • Report Fraud / Join a Case
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Email